ALS Crisis Of Conscience At FDA Spells Opportunity For Neuralstem, Brainstorm

Ted Harada became something of a mini celebrity back in March 2011 when he became the final patient of 15 in a phase I trial for NSI-566, Neuralstem's flagship experimental ALS stem cell treatment.

http://seekingalpha.com/article/1254791-als-crisis-of-conscience-at-fda-spells-opportunity-for-neuralstem-brainstorm?source=feed